FDA recalls over 11 million Rohto eye drop cartons
TAIPEI, Taiwan & OSAKA, Japan--(BUSINESS WIRE)--iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational ...
Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. to broaden the access to its core technology that transforms smartphones into ...
Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, ...
Rohto Pharmaceutical Co (JP:4527) has released an update. Rohto Pharmaceutical Co. reported a significant decline in profits for the first half of fiscal year 2025, with net income dropping by ...
Rohto Pharmaceutical has been shaping the story of eye health for more than a century, beginning with the launch of its first eye drops in 1909. Today, eye drops represent over 80% of sales within ...
Fund manager Asset Value Investors has intensified its campaign against Rohto Pharmaceutical Co. [Tokyo:4527], escalating a year-long effort to push for strategic and governance changes by calling ...
Rohto Pharmaceutical reveals figures for Q4 on May 12. Analysts expect earnings per share of ¥24.60. Go here to follow Rohto Pharmaceutical stock price in real-time on Markets Insider. On May 12, ...
Detailed price information for Coca-Cola Company (KO-N) from The Globe and Mail including charting and trades.
The average one-year price target for Rohto Pharmaceutical (TYO:4527) has been revised to 4,494.80 / share. This is an increase of 23.96% from the prior estimate of 3,626.10 dated August 31, 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results